Improving management and collaboration in cardiometabolic disease research
Leadership Administration Core
This study is looking at how being male or female affects the risk and treatment of heart and metabolic diseases, and it's designed to help researchers work together better and share what they learn with everyone.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of California Los Angeles NIH-funded |
| Lab location | 1 site (Los Angeles, United States) |
| Project ID | NIH-10919846 on NIH RePORTER |
What this research studies
This research focuses on enhancing the efficiency and effectiveness of administrative processes in the study of cardiometabolic diseases, particularly by examining how biological sex influences risk and treatment. Led by Dr. Karen Reue, the project aims to foster collaboration among various research teams and organize educational events to disseminate findings. The Leadership Administrative Core will coordinate resources and support scientific productivity through strategic management and advisory consultations. By integrating insights from multiple disciplines, the project seeks to advance understanding in this critical area of health.
Who could benefit from this research
Good fit: Ideal candidates for benefiting from this research include individuals at risk for or diagnosed with cardiometabolic diseases, particularly those interested in how sex differences may affect their treatment.
Not a fit: Patients who do not have cardiometabolic diseases or are not interested in the implications of sex differences in treatment may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved strategies for diagnosing and treating cardiometabolic diseases, tailored to the specific needs of different sexes.
How similar studies have performed: Previous research has shown success in improving administrative efficiency and collaboration in health studies, making this approach promising.
Where this research is happening
Los Angeles, United States
- University of California Los Angeles — Los Angeles, United States (Active)
Researchers
- Principal investigator: Reue, Karen — University of California Los Angeles
- Study coordinator: Reue, Karen
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.